Personal
Professional
Research
Personal Professional Research Sign Up Login Pro Login
Research Virulence Factor, babA
GI-MAP Interpretive Guide by Diagnostic Solutions Diagnostic Solutions Laboratory

Virulence Factor, babA

Optimal Result: 0 - 0.0001 Units.

Helicobacter pylori BabA Adhesin: A Key Virulence Factor in Gastric Disease

Helicobacter pylori is a gram-negative, spiral-shaped bacterium that colonizes the human stomach, affecting approximately 50% of the global population. While many infections remain asymptomatic, H. pylori can cause a spectrum of gastric diseases, ranging from chronic gastritis to peptic ulcers and gastric cancer. The bacterium's ability to persist in the harsh gastric environment is largely attributed to its virulence factors, with BabA (blood group antigen-binding adhesin) playing a crucial role in pathogenesis.

BabA Structure and Function

BabA, encoded by the babA2 gene, is an outer membrane protein that enables H. pylori to adhere to gastric epithelial cells. It specifically binds to Lewis b (Leb) blood group antigens present on the stomach lining. Recent structural studies have revealed the molecular basis of this interaction, showing that BabA recognizes specific fucosylated blood group antigens with high affinity. The adhesion mediated by BabA is critical for H. pylori's colonization strategy:

  1. It allows the bacterium to resist the stomach's natural defense mechanisms, such as the constant shedding of epithelial cells.
  2. It facilitates the delivery of other virulence factors, like CagA and VacA, to host cells.
  3. It enhances the inflammatory response, contributing to chronic gastritis and tissue damage.

Clinical Significance of BabA

Numerous studies have demonstrated the clinical relevance of BabA-positive H. pylori strains:

→ A meta-analysis of 25 studies found that babA2-positive strains were associated with a significantly increased risk of peptic ulcer disease (OR: 2.069, 95% CI: 1.530-2.795) and gastric cancer (OR: 2.753, 95% CI: 1.969-3.846) .

→ BabA expression has been linked to more severe gastric inflammation, atrophy, and intestinal metaplasia, which are precursors to gastric cancer .

→ The presence of BabA, especially in combination with other virulence factors like CagA and VacA, is associated with a higher risk of gastric adenocarcinoma .

BabA and Blood Group Interactions

An intriguing aspect of BabA's function is its differential binding to ABO blood group antigens:

→ Individuals with blood group O express higher levels of Leb antigens, potentially increasing their susceptibility to H. pylori colonization.

→ A study of 2,123 patients found that those with blood group O had a significantly higher prevalence of peptic ulcers (OR: 1.37, 95% CI: 1.07-1.74) when infected with H. pylori .

This interaction between BabA and blood group antigens highlights the potential for personalized risk assessment in H. pylori infections.

Treatment Considerations

The presence of BabA-positive H. pylori strains may warrant more aggressive treatment approaches:

→ Standard triple or quadruple antibiotic therapies remain the primary treatment, but eradication rates may be lower in BabA-positive strains .

→ Adjunct therapies targeting adhesion, such as specific glycan inhibitors or anti-adhesin antibodies, are under investigation .

→ Probiotics and certain phytochemicals have shown promise in reducing H. pylori colonization and may be particularly beneficial against virulent strains .

Conclusion

BabA is a critical virulence factor in H. pylori pathogenesis, mediating strong adhesion to gastric epithelial cells and enhancing the delivery of other bacterial toxins. Its presence is associated with an increased risk of severe gastric diseases, including peptic ulcers and gastric cancer. Detection of BabA in clinical isolates provides valuable information for risk stratification and may guide more tailored treatment approaches. Ongoing research into BabA-targeted therapies offers promising avenues for improving H. pylori eradication strategies and reducing the global burden of H. pylori-associated diseases.

References:

Wroblewski, L. E., Peek, R. M., & Wilson, K. T. (2010). Helicobacter pylori and gastric cancer: Factors that modulate disease risk. Clinical Microbiology Reviews, 23(4), 713–739.

Harris, P. R., et al. (2008). Helicobacter pylori and molecular mimicry in gastric cancer. Expert Review of Molecular Medicine, 10, e29.

Odenbreit, S. (2005). Pathogenesis of Helicobacter pylori infection. Helicobacter, 10(Suppl. 1), 14–18.

Blaser, M. J., & Atherton, J. C. (2004). Helicobacter pylori persistence: Biology and disease. Journal of Clinical Investigation, 113(3), 321–333.

Cover, T. L., & Blaser, M. J. (2009). Helicobacter pylori in health and disease. Gastroenterology, 136(6), 1863–1873.

Malfertheiner, P., et al. (2012). Management of Helicobacter pylori infection—the Maastricht IV/Florence Consensus Report. Gut, 61(5), 646–664.

Hatakeyama, M. (2014). Helicobacter pylori CagA and gastric cancer: A paradigm for hit-and-run carcinogenesis. Cell Host & Microbe, 15(3), 306–316.

Sugimoto, M., et al. (2010). Role of Helicobacter pylori infection in gastric cancer. World Journal of Gastroenterology, 16(27), 3380–3385.

Diagnostic Solutions Laboratory. GI-MAP Test: Helicobacter pylori and virulence factors. Diagnostic Solutions Laboratory.

Yamaoka, Y., et al. (2002). Relationship of Helicobacter pylori BabA2, CagA, and VacA status to clinical outcomes: Studies in four different countries. Journal of Clinical Microbiology, 40(4), 1333–1338.

de Reuse, H., & Bereswill, S. (2005). Helicobacter pylori virulence factors: Urease and motility. Helicobacter, 10(Suppl. 1), 30–36.

What does it mean if your Virulence Factor, babA result is too high?

A positive result for the Helicobacter pylori virulence factor BabA (blood group antigen-binding adhesin) indicates the presence of a more virulent strain of H. pylori that binds strongly to the gastric epithelial cells, facilitating persistent infection and increasing the risk of severe gastrointestinal diseases like peptic ulcers, chronic gastritis, and gastric cancer.

This adhesion also enables the bacteria to resist the stomach's natural defense mechanisms, leading to more aggressive colonization.

BabA often works synergistically with other virulence factors, such as CagA and VacA, amplifying the pathogenic potential and increasing the likelihood of inflammation and mucosal damage. Individuals with blood group O are particularly susceptible to severe outcomes, as BabA-positive strains preferentially bind to Lewis b antigens prevalent in this group. Given the increased risk, patients with a positive BabA result may require more intensive treatment and monitoring to prevent serious complications.

While BabA itself is not directly treated, the presence of the babA virulence factor in Helicobacter pylori infections can influence how the overall infection is managed. Treatment focuses on eradicating the H. pylori bacterium, which in turn eliminates the effects of BabA and other virulence factors that contribute to disease.

Treatment approaches include:

  1. Antibiotic Therapy:

    • Standard treatment for H. pylori, including BabA-positive strains, typically involves a combination of antibiotics such as clarithromycin, amoxicillin, metronidazole, or tetracycline, often in combination with a proton pump inhibitor (PPI) to reduce stomach acid. The presence of BabA may indicate a more virulent strain, requiring careful selection of antibiotics and sometimes a longer course of treatment.

  2. Proton Pump Inhibitors (PPIs):

    • PPIs, such as omeprazole or esomeprazole, are used to lower stomach acidity, which helps to heal the stomach lining and makes the environment less favorable for H. pylori. This is part of the standard therapy regardless of BabA presence.

  3. Anti-Adhesion Therapies:

    • Although not standard yet, research is ongoing into therapies that specifically target bacterial adhesion mechanisms. In the case of BabA-positive strains, anti-adhesion compounds or therapies could potentially block BabA’s ability to bind to the gastric epithelium, reducing colonization and persistence of the infection.

  4. Botanical and Natural Compounds:

    • Certain natural compounds, like curcumin (from turmeric), polyphenols (like those in green tea or berries), and terpenoids (found in citrus peels), have shown promise in inhibiting H. pylori adhesion and reducing bacterial load. While these are not primary treatments, they may be used alongside antibiotics to help control the infection, especially in resistant strains.

Although BabA cannot be targeted directly by current treatments, managing the infection through antibiotic therapy and adjunct approaches can reduce the virulence and disease potential associated with BabA-positive H. pylori strains.

Frequently asked questions

Healthmatters is a highly-personalized health dashboard.

Instead of searching for your lab results in different places or tracking them down from different providers, Healthmatters houses, organizes, and interprets them all in one central location.

With a Healthmatters account, you can dive into the details of each biomarker and gain insights into the meaning behind your medical test data, anytime, anywhere.

For our professional users, Healthmatters provides intuitive tools that not only streamline analysis but also save valuable time when delving into your client's lab report history.

Healthmatters.io personal account provides in-depth research on 4000+ biomarkers, including information and suggestions for test panels such as, but not limited to:

  • The GI Effects® Comprehensive Stool Profile,
  • GI-MAP,
  • The NutrEval FMV®,
  • The ION Profile,
  • Amino Acids Profile,
  • Dried Urine Test for Comprehensive Hormones (DUTCH),
  • Organic Acids Test,
  • Organix Comprehensive Profile,
  • Toxic Metals,
  • Complete Blood Count (CBC),
  • Metabolic panel,
  • Thyroid panel,
  • Lipid Panel,
  • Urinalysis,
  • And many, many more.

You can combine all test reports inside your Healthmatters account and keep them in one place. It gives you an excellent overview of all your health data. Once you retest, you can add new results and compare them.

If you are still determining whether Healthmatters support your lab results, the rule is that if you can test it, you can upload it to Healthmatters.

While we work with many popular labs, we welcome reports from lots of other places too.

It's as simple as this: if you can get a test done, you can upload it to Healthmatters and we can interpret results from any lab out there. If laboratories can analyze it, we can interpret it.

If you’re on the hunt for a specific biomarker, contact us and we'll add it to our database. Anything from blood, urine, saliva, or stool can be uploaded, understood, and tracked with your Healthmatters account.

There are two ways to add your test reports to your Healthmatters account. One option is to input the data using the data entry forms. The other method is to utilize our "Data entry service."

Our data entry forms offer an easy, fast, and free way for you to input the reports yourself. Self-entry allows you to add an unlimited number of reports at no cost. We make the self-entry process user-friendly, providing dozens of templates that pre-populate the most popular laboratory panels and offering instant feedback on entered values.

For those who prefer assistance, we offer a "Data entry service" to help you input your data. Simply attach an image or file of your lab test results, and a qualified team member from our data entry team will add the results for you.

We support various file types, including PDFs, JPGs, or Excel. This service is particularly useful if you have many reports to upload or if you're too busy to handle the data entry yourself.

Our special data entry service makes it easy to add your results to your private dashboard. Just attach an image or a file of your lab test results, and our skilled data entry team will do the work for you. It's all done by humans, ensuring that your data is entered accurately and with personal care for each client.

Depending on your account, the data entry service can be included for free or come at an additional cost of $15 per report.

For users on the Complete monthly plan, the first report is entered free of charge, and each additional report incurs a fee of $15.

Unlimited account holders enjoy the entry of ten reports without charge. Subsequent reports are subject to a $15 fee per report.

Additionally, users on the Complete plan can upgrade to a yearly subscription from the account settings. The annual subscription includes a data entry service for five reports.

The Unlimited plan is a one-time purchase for $250, and it covers your account for a lifetime with no additional payments.

For the Complete plan, the cost is $15 per month. You have the flexibility to cancel it anytime through your account settings, ensuring no further payments. To avoid charges, remember to cancel at least a day before the renewal date. Once canceled, the subscription remains active until the end of the current billing cycle.

Additionally, you can upgrade to the yearly Advanced plan from within your account. The annual cost is $79, and it comes with a data entry service for five reports.

You can always upgrade to a lifetime version with a prorated price from a monthly or yearly subscription.

Simply log in and navigate to your account settings to cancel your subscription. Scroll down to locate the 'Cancel' button at the bottom of the page. Ensure you cancel at least one day before the renewal date to prevent any charges. Once cancellation is requested, the subscription remains active until the conclusion of the current billing cycle.

Our goal has been to make your Healthmatters account as intuitive as possible.

We’ve crafted multiple ways for you to navigate your data, whether you're glancing at a single report or delving into your historical test reports.

1. Graph View:

Dive into a visual journey with our biomarker graphs, showcasing over 40 data points. Combining years of results unveils trends, empowering you to make informed decisions. Our visualization tools make it a breeze to compare and understand changes over time, even if your results are from different labs. A search function and filters simplify the exploration of extensive data, allowing you to focus on what needs attention.

2. All Tests View

Explore neatly organized reports on a timeline, highlighting crucial details like dates, critical results, and lab/panel names. Each report opens up to reveal in-depth descriptions and additional recommendations for each biomarker. The history of previous results is just a click away, and you can download a comprehensive report for deeper insights. Color-coded and user-friendly, it's designed for easy reading, understanding, and navigation.

3. Table View:

For a holistic view of all biomarkers side by side, our table view is your go-to. Results are neatly displayed in a categorized and dated table, ideal for those with an extensive test history. Utilize sorting, filters, and color-coding to enhance your analysis and gain extra insights.

Yes, you can download information from your account. We can compile your labs into a CSV file. To download all your labs, you can go to Account Settings, and at the bottom of the page, you will find a link to download your information.

Yes, you can print your report. To do so, navigate to "All tests" and open the report you wish to print. You'll find a print button in the right corner of the report. Click on it, and your browser's print window will open. If you prefer to print in a bigger typeface, adjust the scale using the print window settings.

Yes, you can! We highly recommend activating Two-Factor Authentication (2FA) for your account. To do so, please navigate to the "Profile and Security" section of your account, where you will find instructions for activating 2FA.

Yes, you can. When entering values for the biomarker, you will see an "Edit Range" button. Click this button, and you'll have the option to enter a custom range.

A personal account is all about keeping your own lab test results in check. It's just for you and your personal use.

The professional account is designed for health professionals who wish to track and organize their clients' laboratory results.

To learn more about Healthmatters Pro, please refer to the professional page.

Use promo code to save 10% off any plan.


We implement proven measures to keep your data safe.

At HealthMatters, we're committed to maintaining the security and confidentiality of your personal information. We've put industry-leading security standards in place to help protect against the loss, misuse, or alteration of the information under our control. We use procedural, physical, and electronic security methods designed to prevent unauthorized people from getting access to this information. Our internal code of conduct adds additional privacy protection. All data is backed up multiple times a day and encrypted using SSL certificates. See our Privacy Policy for more details.

Navigate to GI-MAP Interpretive Guide by Diagnostic Solutions

Popular search

A2142C, A2142G, A2143G, A926G, Adenovirus 40/41, AGA926-928TTC, Akkermansia muciniphila, Amoxicillin, Ancylostoma duodenale, Anti-gliadin IgA, Ascaris lumbricoides, b-Glucuronidase, Bacillus spp., Bacteroides fragilis, Bacteroidetes, Bifidobacterium spp., Blastocystis hominis, C. difficile, Toxin A, C. difficile, Toxin B, Calprotectin, Campylobacter, Candida albicans, Candida spp., Chilomastix mesnili, Citrobacter freundii, Citrobacter spp., Clarithromycin, Clostridia (class), Cryptosporidium, Cyclospora spp., Cytomegalovirus, Desulfovibrio spp., Dientamoeba fragilis, E. coli O157, Elastase-1, Endolimax nana, Entamoeba coli, Entamoeba histolytica, Enterobacter spp., Enterococcus faecalis, Enterococcus faecium, Enterococcus spp., Enterohemorrhagic E. coli (EHEC), Enteroinvasive E. coli/Shigella, Enterotoxigenic E. coli LT/ST, Eosinophil Activation Protein (EDN/EPX), Epstein-Barr Virus, Escherichia spp., Faecalibacterium prausnitzii, Firmicutes, Firmicutes:Bacteroidetes Ratio, Fluoroquinolones, Fusobacterium spp., Geotrichum spp., Giardia, Gluten Peptide, gyrA D91G, gyrA D91N, gyrA N87K, gyrB R484K, gyrB S479N, Helicobacter pylori, Klebsiella pneumoniae, Klebsiella spp., Lactobacillus spp., M. avium subsp. paratuberculosis, Methanobacteriaceae (family), Microsporidium spp., Morganella spp., Necator americanus, Norovirus GI/II, Occult Blood - FIT, PBP1A N562Y, PBP1A S414R, PBP1A T556S, Pentatrichomonas hominis, Prevotella spp., Proteus mirabilis, Proteus spp., Pseudomonas aeruginosa, Pseudomonas spp., Rhodotorula spp., Rodotorula spp., Roseburia spp., Salmonella, Secretory IgA, Shiga-like Toxin E. coli stx1, Shiga-like Toxin E. coli stx2, Staphylococcus aureus, Staphylococcus spp., Steatocrit, Streptococcus spp., Taenia spp., Tetracycline, Trichuris trichiura, Vibrio cholerae, Virulence Factor, babA, Virulence Factor, cagA, Virulence Factor, dupA, Virulence Factor, iceA, Virulence Factor, oipA, Virulence Factor, vacA, Virulence Factor, virB, Virulence Factor, virD, Yersinia enterocolitica, Zonulin